Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2026-01-11 @ 6:42 PM
Study NCT ID:
NCT01161550
Status:
COMPLETED
Last Update Posted:
2013-07-23
First Post:
2010-07-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML
Sponsor:
Washington University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-09
First Submit QC Date:
None
Study First Post Date:
2010-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-22
Last Update Post Date:
2013-07-23
Last Update Post Date Type:
ESTIMATED